Brad Schweizer, Investor Relations Manager with ATDC, has extensive background in venture capital, mergers and acquisitions, significant financial modeling experience and private equity as an associate at Morris, Manning & Martin (MMM). He will be able to help companies understand the impact a financing round might have on their cap table, pro-formas, and option pools, among other considerations.
As an entrepreneur, Brad was co-founder and chief operating officer of Dedo.ai, a health technology company.
Prior that, he served as COO of Aces Health, a startup with a focus on complex clinical trials. In that role, he not only gained the operating experience of leading a startup, but also the experience of navigating complex regulatory environments and communicating these intricate details to investors in a way that was easy to understand.
At Aces Health, he led the financing rounds and raised approximately $2.5 million for the company through a variety of instruments, including SAFEs (simple agreement for future equity), convertible notes, warrants, and preferred shares.
A St. Louis, Missouri native, Brad has a joint law degree and MBA from Emory University, and a bachelor’s degree in accounting and finance from the Kelley School of Business at Indiana University.
Connect with Brad on LinkedIn.
